Story preview
Continue reading on the publisher site for the full article.
Read on publisher →Foreign Policy Journal
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Outlets covering it
13
in the last 3 days
First reported
3 days ago
11 outlets since
Countries
12 other outlets reported this story in the last 3 days.
Rocket Lab (RKLB) Neutron delay to 2027, dilution risks, and Iridium deal—yet strong margins, FCF growth, and defense tailwinds. See more here.
Investing.com -- Rocket Lab Corporation (NASDAQ:RKLB) shares fell 7% in after-hours trading Wednesday after the company announced it was pushing back the debut of its Neutron launch vehicle to 2027.
The SpaceX rival announced another delay to its medium-lift Neutron rocket.